• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.87% Nasdaq Up 0.34%

    Arrowhead Research Corp. (ARWR)

    -NasdaqGS
    6.55 Up 0.16(2.50%) Dec 22, 4:00PM EST
    |After Hours : 6.45 Down 0.10 (1.53%) Dec 22, 5:59PM EST
    Add to Portfolio
    Prev Close:6.39
    Open:6.30
    Bid:N/A
    Ask:7.30 x 300
    1y Target Est:17.75
    Beta:3.16
    Earnings Date:Feb 2 - Feb 6 (Est.)
    Day's Range:6.11 - 6.75
    52wk Range:4.95 - 27.63
    Volume:2,199,080
    Avg Vol (3m):3,834,490
    Market Cap:358.17M
    P/E (ttm):N/A
    EPS (ttm):-1.25
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ARWR

    Comparison

    Symbol% ChgMkt Cap
    ARWRUp 2.50%358.17M
    PENCDown 9.54%19.62M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1,996.69
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Sep-15) :-1.53
    Quarterly EPS Est (Dec-14) :-0.34
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):-0.54

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Arrowhead Research Corporation develops novel drugs to treat intractable diseases in the United States. The company’s principal product candidates comprise ARC-520, an RNAi-based therapeutic that is in Phase IIa clinical trial to treat chroni... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback